The global market for STAB2 Antibody (Stabilin-2 Precursor) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Stabilin-2 is a protein that in humans is encoded by the STAB2 gene.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This repo...
The global market for TSG6 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
TSG-6 forms a stable complex with the serine protease inhibitor Inter-alpha -Inhibitor (I alpha I) and potentiates the anti-plasmin activity of I alpha I. Tumor Necrosis Factor-stimulated Gene Sequence 6.
I...
The global market for CSPG2 Antibody (Versican) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Versican (VCAN), also known as CSPG2, is a large extracellular matrix proteoglycan that is present in a variety of human tissues. Versican is a large chondroitin sulfate proteoglycan with an app...
The global market for CHST15 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CHST15 (Carbohydrate Sulfotransferase 15) is a Protein Coding gene. Diseases associated with CHST15 include Spondyloepiphyseal Dysplasia With Congenital Joint Dislocations and Larsen Syndrome.
In terms of...
The global market for EXT1 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EXT1 Antibody (A-7) is an IgG1 κ mouse monoclonal EXT1 antibody (also designated EXT1 antibody) that detects the EXT1 protein of mouse, rat and human origin by WB, IP, IF and ELISA.
In terms of regions, Nor...
The global market for EXTL1 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EXTL1 (Exostosin Like Glycosyltransferase 1) is a Protein Coding gene. Diseases associated with EXTL1 include Hereditary Multiple Exostoses and Exostosis.
In terms of regions, North America is expected to...
The global market for EXTL2 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EXTL2 (Exostosin Like Glycosyltransferase 2) is a Protein Coding gene. Diseases associated with EXTL2 include Hereditary Multiple Exostoses and Breast Pericanalicular Fibroadenoma. Among its related pathwa...
The global market for EXTL3 Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EXTL3 (Exostosin Like Glycosyltransferase 3) is a Protein Coding gene. This gene encodes a single-pass membrane protein which functions as a glycosyltransferase. The encoded protein catalyzes the transfer...
The global market for FAM20B Gene (XYLK Antibody) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
FAM20B (FAM20B Glycosaminoglycan Xylosylkinase) is a Protein Coding gene. Diseases associated with FAM20B include Desbuquois Dysplasia and Gingival Fibromatosis. Gene Ontology (GO) annotations...
The global market for GNS Glucosamine (GNS Antibody) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
GNS (Glucosamine (N-Acetyl)-6-Sulfatase) is a Protein Coding gene. Diseases associated with GNS include Mucopolysaccharidosis, Type Iiid and Mucopolysaccharidosis Iii. Among its related pat...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals